|Last Price||Today's Change||52-Week Range||Trading Volume|
|74.70||0.00 (0.00%)||62.80 - 77.31||79.0 thousand (Below Avg)|
Market data as of 12:00AM 09/12/14. Quotes are delayed by at least 15 min.
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency
09/12/2014 7:02 PM ET
Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company
09/10/2014 4:30 PM ET